10x Genomics Inc. (TXG) Fundamentals

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
SHARE INFORMATION
Market Cap$ 4,460,643,413
Shares Outstanding114,463,521
Float92,412,851
Percent Float80.74%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 490,490,000
Latest Fiscal EPS$ -0.53
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions786
Institutional Holdings Date2022-11-30
Institutional Bought Previous 3 Months16,545,861
Institutional Holdings Percent154.5%
Institutional Sold Previous 3 Months27,348,955
Insider Holdings Date2022-11-30
Insider Bought Previous 3 Months982,743
Insider Holdings Percent1.6
Insider Sold Previous 3 Months28,163
Insider Shares Owned1,847,773
TRADING INFO
52 Week High$ 154.80
52 Week Low$ 23.81
52 Week High Change$ -73.74
21 Day Moving Average$ 36.11
21 Day Extended Moving Average$ 35.572
50 Day Moving Average$ 31.3502
50 Day Extended Moving Average$ 33.9506
200 Day Moving Average$ 45.9292
200 Day Extended Moving Average$ 53.3766
10 Day Average Volume924,440
20 Day Average Volume1,330,280
30 Day Average Volume1,453,070
50 Day Average Volume1,288,153
Alpha-0.010073
Beta1.7010
Standard Deviation0.165942
R20.361039
7 Day Price Change$ 3.13
7 Day Percent Change8.73%
21 Day Price Change$ -2.33
21 Day Percent Change-5.64%
30 Day Price Change$ 12.05
30 Day Percent Change44.76%
Month to Date Price Change$ 0.31
Month to Date Percent Change0.8%
Quarter to Date Price Change$ 10.49
Quarter to Date Percent Change36.83%
180 Day Price Change$ -11.25
180 Day Percent Change-22.4%
200 Day Price Change$ -7.33
200 Day Percent Change-15.83%
Year to Date Price Change$ -109.99
Year to Date Percent Change-73.84%

10x Genomics Inc. (TXG) Key Ratios

PROFITABILITY
EBIT Margin-32.0%
EBITDA Margin-25.6%
Pre-Tax Profit Margin-61.2%
Profit Margin Count-33.2%
Gross Margin77.9%
Profit Margin TOT-33.2%
INCOME STATEMENTS
Revenue$ 503,707,000
Revenue Per Share$ 5.2691
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book6.00
Total Debt To Equity0.10
Int Coverage-283.40
Current Ratio5.00
Leverage Ratio1.30
Quick Ratio4.20
Long Term Debt To Capital0.10
VALUATION MEASURES
PE Ratio-26.20
Enterprise Value$ 4,104,483,413
Price to Sales7.3959
Price to Free Cash-27.40
PE High Last 5 Years0.00
Price To Book5.80
Price To Cash Flow199.90
PE Low Last 5 Years0.00
Price to Tangible Book6.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.10
Invoice Turnover1.70
Assets Turnover0.20
Return Assets-16.83
Return on Equity-21.22
Return on Capital-19.31

10x Genomics Inc. (TXG) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOSerge Saxonov
Emplyoees1239
Last AuditUQ
CIK0001770787
IndustryHealthcare Providers & Services
SectorHealthcare
NAICSAll Other Miscellaneous Ambulatory Health Care Services(621999)
CONTACT INFO
Address6230 Stoneridge Mall Road
Pleasanton, CA 94588
Websitehttps://www.10xgenomics.com
Facsimile-
Telephone+1 925 401-7300
Emailinvestors@10xgenomics.com


Your Recent History
NASDAQ
TXG
10x Genomi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.